Results 241 to 250 of about 150,491 (260)

Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial

Lancet, The, 2023
Sylvain Losdat, Christoph Kaiser, Dik Heg   +2 more
exaly  

A scalable metal-organic framework as a durable physisorbent for carbon dioxide capture

Science, 2021
Jian-Bin Lin, Tran Thanh Tai Nguyen, Ramanathan Vaidhyanathan   +2 more
exaly  

Atomically dispersed iron sites with a nitrogen–carbon coating as highly active and durable oxygen reduction catalysts for fuel cells

Nature Energy, 2022
Shengwen Liu, Chenzhao Li, Michael J Zachman   +2 more
exaly  

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

Lancet, The, 2011
Giulio G Stefanini, Bindu Kalesan, Dik Heg   +2 more
exaly  

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Lancet, The, 2008
Stephan Windecker, Patrick W Serruys, Pawel Buszman   +2 more
exaly  

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

Lancet, The, 2017
David E Kandzari, Joseph M Massaro, Hector M Garcia-Garcia   +2 more
exaly  

Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial

Lancet, The, 2018
Thomas M Pilgrim, Raffaele Piccolo, Dik Heg   +2 more
exaly  

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

Lancet, The, 2014
Thomas M Pilgrim, Dik Heg, Olivier Muller   +2 more
exaly  

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial

Lancet, The, 2019
Juan F Iglesias, Olivier Muller, Dik Heg
exaly  

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

Lancet, The, 2015
Lisette Okkels Jensen, Hans-Henrik Tilsted, Evald Christiansen   +2 more
exaly